Bioventix plc (AIM: BVXP) announces that it has today applied for 47,725 ordinary shares of 5 pence each (the “Option Shares”) to be admitted to trading on AIM (“Admission”). It is expected that Admission will occur and that dealings will commence in the Option Shares on 18 July 2016. (more…)

Director’s report and financial statements for the year ended 30th June 2016. (more…)

TR-1: Notification of major interest in shares. (more…)

Pre Diagnostics and Bioventix enter collaboration on blood-based beta amyloid Alzheimer’s diagnostic test. (more…)

TR-1: Notification of major interest in shares. (more…)

Unaudited interim results for the six months ended 31st December 2015. (more…)

Companies to jointly develop “missing link” Secretoneurin biomarker. (more…)

Unaudited interim results for the six months ended 31st December 2015. (more…)

Director’s report and financial statements for the year ended 30th June 2015. (more…)

Unaudited interim results for the six months ended 31st December 2014. (more…)